Selective BET bromodomain inhibition as an antifungal therapeutic strategy.

Abstract : Invasive fungal infections cause significant morbidity and mortality among immunocompromised individuals, posing an urgent need for new antifungal therapeutic strategies. Here we investigate a chromatin-interacting module, the bromodomain (BD) from the BET family of proteins, as a potential antifungal target in Candida albicans, a major human fungal pathogen. We show that the BET protein Bdf1 is essential in C. albicans and that mutations inactivating its two BDs result in a loss of viability in vitro and decreased virulence in mice. We report small-molecule compounds that inhibit C. albicans Bdf1 with high selectivity over human BDs. Crystal structures of the Bdf1 BDs reveal binding modes for these inhibitors that are sterically incompatible with the human BET-binding pockets. Furthermore, we report a dibenzothiazepinone compound that phenocopies the effects of a Bdf1 BD-inactivating mutation on C. albicans viability. These findings establish BET inhibition as a promising antifungal therapeutic strategy and identify Bdf1 as an antifungal drug target that can be selectively inhibited without antagonizing human BET function.
Type de document :
Article dans une revue
Nature Communications, Nature Publishing Group, 2017, 8, pp.15482. 〈10.1038/ncomms15482〉
Liste complète des métadonnées

Littérature citée [71 références]  Voir  Masquer  Télécharger

http://hal.univ-grenoble-alpes.fr/hal-01537809
Contributeur : Frank Thomas <>
Soumis le : mercredi 3 janvier 2018 - 17:19:04
Dernière modification le : lundi 19 février 2018 - 14:34:04

Fichier

Selective BET bromodomain inhi...
Publication financée par une institution

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Citation

Flore Mietton, Elena Ferri, Morgane Champleboux, Ninon Zala, Danièle Maubon, et al.. Selective BET bromodomain inhibition as an antifungal therapeutic strategy.. Nature Communications, Nature Publishing Group, 2017, 8, pp.15482. 〈10.1038/ncomms15482〉. 〈hal-01537809〉

Partager

Métriques

Consultations de la notice

543

Téléchargements de fichiers

1255